Id Biomedical Corp.
Country not established
- Devices
- 3
What Id Biomedical Corp. makes
Id Biomedical Corp. develops molecular diagnostic assays for rapid identification of bacterial infections, including *Vancomycin-resistant Enterococci* (VRE) and *Methicillin-resistant Staphylococcus aureus* (MRSA). Their assays are designed for point-of-care or laboratory use, enabling quick detection and differentiation of resistant pathogens.
The company’s portfolio consists of Class II devices, each authorised via the FDA’s 510(k) clearance process. These assays are listed under the FDA’s regulatory framework and are intended for use in clinical settings to support infection control and antimicrobial stewardship decisions.
Catalogue
Velogene Genomic Identificationassay For Vre Ref K020576
Regimes: 510(k) Registry: 510(k)- Regimes: 510(k) Registry: 510(k)
Velogene Rapid Mrsa Identification Assay Ref K990640
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Id Biomedical Corp. have in the registry?
The registry currently lists 3 devices for Id Biomedical Corp.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Id Biomedical Corp.'s devices?
Among its 3 most recently registered devices, Id Biomedical Corp. has devices listed in FDA 510(k) (3 devices).
What risk classes do Id Biomedical Corp.'s devices fall under?
Among its 3 most recently registered devices, the classes recorded for Id Biomedical Corp.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Id Biomedical Corp. in the registry?
The most recently registered devices listed for Id Biomedical Corp. include VELOGENE GENOMIC IDENTIFICATIONASSAY FOR VRE, VELOGENE GENOMIC IDENTIFICATION ASSAY FOR MRSA WITH ONE-STEP DETECTION and VELOGENE RAPID MRSA IDENTIFICATION ASSAY.